BiPar Sciences Inc. subsiadry of Sanofi-aventis Group
|
|
|
|
400 OysterPoint Blvd. Suite 200 South San Francisco. CA 94080 USA |
| |
|
|
+1-650-228-1880 |
|
|
+1-650-228-1083 |
|
|
www.biparsciences.com |
|
|
|
|
|
|
cancer therapy; PARP inhibitors; lead product candidate BSI-201; targets PARP or poly (ADP-ribose) polymerase; a key enzyme involved in DNA repair and cell proliferation | |
Korean Distributor : »ç³ëÇÇ-¾Æº¥Æ¼½º ÄÚ¸®¾Æ (Sanofi-aventis Korea) |
Products information :
|
|
|
|
|
|
|
|
|
|